Welcome to our dedicated page for BlackRock Science and Tech Term ord news (Ticker: BSTZ), a resource for investors and traders seeking the latest updates and insights on BlackRock Science and Tech Term ord stock.
BlackRock Science and Tech Term Trust (BSTZ) provides investors with focused exposure to innovative companies driving scientific advancement. This page serves as the definitive source for all official news releases, financial developments, and strategic updates related to this closed-end fund.
Access timely information about BSTZ's portfolio adjustments, earnings disclosures, and management insights. Investors can track announcements regarding dividend distributions, sector-specific investments, and risk management strategies while analysts monitor regulatory filings and market positioning.
Key content categories include quarterly financial results, material asset allocation changes, corporate governance updates, and strategic partnership announcements. All information is sourced directly from BlackRock's investor relations team and regulatory filings to ensure accuracy.
Bookmark this page for convenient access to BSTZ's evolving investment narrative. Combine these updates with independent research to inform your analysis of this technology-focused closed-end fund.
BlackRock announced final results for tender offers of three closed-end funds. The offers, which expired on November 19, 2024, were oversubscribed for each fund. Each fund will purchase shares from tendering shareholders on a pro rata basis. For BlackRock Science and Technology Term Trust (BSTZ), 19,714,994 shares were tendered, with 1,854,222 to be purchased at $22.3440 per share, representing a pro-ration factor of 0.09414755. Similar results were reported for BCX and BOE funds. Payments are expected within five business days after expiration.
BlackRock announced the expiration and preliminary results of tender offers for three closed-end funds: BSTZ, BCX, and BOE. Each fund offered to repurchase up to 2.5% of its outstanding common shares. The tender offers were significantly oversubscribed, with BCX receiving 20,587,371 shares tendered against 2,056,355 shares offered for repurchase. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of November 20, 2024.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The offers, which expired on August 20, 2024, were oversubscribed for each fund. As a result, shares will be purchased from all tendering shareholders on a pro rata basis. The BlackRock Science and Technology Term Trust (BSTZ) had 23,251,771 shares tendered, with 1,901,766 to be purchased at $21.4522 per share. The pro-ration factor for BSTZ is 0.08188543. Two other BlackRock funds, BCX and BOE, also reported their tender offer results. Payments for accepted shares are expected within five business days after the expiration date.
BlackRock closed-end funds BSTZ, BCX, and BOE announced the expiration and preliminary results of their tender offers for up to 2.5% of outstanding common shares. The offers, which began on July 19, 2024, and ended on August 20, 2024, were significantly oversubscribed. BSTZ offered 1,901,766 shares but received tenders for 23,251,771 shares. BCX and BOE also saw high demand, with tenders exceeding the offered amounts by over 10 times. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of August 21, 2024. Final results, including pro-ration factors, are expected to be announced around August 21, 2024.
BlackRock has released its first quarter commentary for Science and Technology Trust II (BSTZ). Since its IPO in June 2019, BSTZ has achieved a remarkable 95% return on market price, exceeding the S&P MidCap 400 Info Tech Index by 28%. In March 2021, BSTZ announced a 49% increase in its monthly distribution, now yielding an annualized rate of 5.4%. The fund currently holds 28 private investments, representing 25% of its portfolio, and indicates a strong pipeline for future investments.
